Paul Trautmann
Obstetrics & Gynecology · San Antonio, TXNPI 1942385091
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $362 and has fallen 96.0% since, to $14 in 2025.
Across 45 payments — averaging $27.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Therapeuticsmd, Inc.$185
- Mayne Pharma Commercial LLC$175
- Abbott$133
- Pacira Pharmaceuticals Incorporated$125
- Roche Diagnostics Corporation$90
- Merck$82
- plus $454 from 17 others
What the payments were for
- Food & beverage$1,244100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Therapeuticsmd, Inc. | 4 | $185 |
| Mayne Pharma Commercial LLC | 5 | $175 |
| Abbott | 1 | $133 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Roche Diagnostics Corporation | 3 | $90 |
| Merck | 5 | $82 |
| AbbVie | 3 | $65 |
| Corium, LLC | 3 | $53 |
| Sanofi Pasteur Inc. | 2 | $48 |
| Biogen | 2 | $44 |
| Agile Therapeutics, Inc. | 2 | $31 |
| Pfizer | 2 | $30 |
| Aspira Women's Health Inc | 2 | $27 |
| Bayer | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Davol Inc. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $14 |
| Shield Therapeutics Inc | 1 | $13 |
| Organon | 1 | $12 |
| Millicent US Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,244 in reported general payments places this provider in the 55th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 12 | $817 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $765 |
| Estradiol | 19 | $757 |
| Alendronate Sodium | 18 | $167 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in San Antonio
- Henry Garza IiiSan Antonio$258K
- Valentin AlmendarezSan Antonio$215K
- Camilo GonimaSan Antonio$203K
- Paulina RamirezSan Antonio$51K
- Paula BilicaSan Antonio$41K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.